Korean J Lab Med.  2010 Apr;30(2):117-121. 10.3343/kjlm.2010.30.2.117.

Clathrin Assembly Lymphoid Myeloid Leukemia-AF10-positive Acute Leukemias: A Report of 2 Cases with a Review of the Literature

Affiliations
  • 1Department of Laboratory Medicine, CHA Bundang Medical Center, CHA University, Seongnam, Korea.
  • 2Department of Laboratory Medicine, Seoul National University Hospital, Seoul, Korea.
  • 3Department of Internal Medicine, CHA Gangnam Medical Center, CHA University, Seoul, Korea.
  • 4Department of Laboratory Medicine, CHA Gangnam Medical Center, CHA University, Seoul, Korea.
  • 5Hematologic Malignancies Branch, Research Institute, National Cancer Center, Goyang, Korea. ksy@ncc.re.kr
  • 6Hematology Oncology Clinic, National Cancer Center, Goyang, Korea.
  • 7Greencross Reference Laboratory, Yongin, Korea.
  • 8Department of Laboratory Medicine, National Cancer Center, Goyang, Korea.

Abstract

The translocation t(10;11)(p13;q14q21) has been found to be recurrent in acute lymphoblastic and myeloid leukemias, and results in the fusion of the clathrin assembly lymphoid myeloid leukemia (CALM) gene with the AF10 gene; these genes are present on chromosomes 11 and 10, respectively. Because the CALM-AF10 rearrangement is a rare chromosomal abnormality, it is not included in routine molecular tests for acute leukemia. Here, we describe the cases of 2 patients with the CALM-AF10 fusion gene. The first patient (case 1) was diagnosed with T-cell ALL, and the second patient (case 2) was diagnosed with AML. Both patient samples showed expression of the homeobox A gene cluster and the histone methyltransferase hDOT1L, which suggests that they mediate leukemic transformation in CALM-AF10-positive and mixed-lineage leukemia-AF10-positive leukemias. Both patients achieved complete remission after induction chemotherapy. The first patient (case 1) relapsed after double-unit cord blood transplantation; there was no evidence of relapse in the second patient (case 2) after allogenic peripheral blood stem cell transplantation. Since CALM-AF10- positive leukemias have been shown to have poor prognosis with conventional therapy, molecular tests for CALM-AF10 rearrangement would be necessary to detect minimal residual disease during follow-up.

Keyword

t(10;11); CALM-AF10; HOXA gene; hDOT1L; Acute leukemia; Reverse transcriptase-PCR

MeSH Terms

Adolescent
Adult
Bone Marrow/pathology
Chromosomes, Human, Pair 10
Chromosomes, Human, Pair 11
Cord Blood Stem Cell Transplantation
Female
Histone-Lysine N-Methyltransferase/genetics/metabolism
Homeodomain Proteins/genetics/metabolism
Humans
Leukemia, Myeloid, Acute/diagnosis/*genetics/therapy
Male
Monomeric Clathrin Assembly Proteins/*genetics
Oncogene Proteins, Fusion/*genetics
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/diagnosis/*genetics/therapy
Recurrence
Transcription Factors/*genetics
Translocation, Genetic

Figure

  • Fig. 1. Bone marrow aspiration shows several lymphoblasts in the first patient (case 1) (A) and myeloblasts in the second patient (case 2) (B) characterized by medium-sized nuclei and prominent nucleoli (Wright-Giemsa stain, ×1,000).

  • Fig. 2. Detection of the CALM-AF10 fusion transcript by RT-PCR in bone marrow cells from cases 1 and 2 and the U937 cell line. A CALM-AF10 fusion transcript of 424 bp was identified in samples of the first (case 1) (A) and second (case 2) (B) patients. Lane M: size marker; lane 1: U937 cell line; lanes 2-4: first patient (case 1) at diagnosis, hematologic remission, and relapse, respectively; lane 5; second patient (case 2) at diagnosis. Abbreviation: CALM-AF10, clathrin assembly lymphoid myeloid leukemia-AF10.

  • Fig. 3. Detection of the HOXA cluster gene and hDOT1L gene expression by RT-PCR in bone marrow cells from cases 1 and 2 and the U937 cell line. Lane 1: U937 cell line; lanes 2-4: first patient (case 1) at diagnosis, hematologic remission and relapse, respectively; lane 5: second patient (case 2) at diagnosis. Abbreviations: HOXA, homeobox A; hDOT1L, human DOT1-like, histone H3 methyltransferase.


Reference

1.Bohlander SK., Muschinsky V., Schrader K., Siebert R., Schlegelberger B., Harder L, et al. Molecular analysis of the CALM/AF10 fusion: identical rearrangements in acute myeloid leukemia, acute lympho-blastic leukemia and malignant lymphoma patients. Leukemia. 2000. 14:93–9.
Article
2.Jones LK., Chaplin T., Shankar A., Neat M., Patel N., Samuel DP, et al. Identification and molecular characterisation of a CALM-AF10 fusion in acute megakaryoblastic leukaemia. Leukemia. 2001. 15:910–4.
Article
3.Nakamura F., Maki K., Arai Y., Nakamura Y., Mitani K. Monocytic leukemia with CALM/AF10 rearrangement showing mediastinal emphysema. Am J Hematol. 2003. 72:138–42.
Article
4.Caudell D., Aplan PD. The role of CALM-AF10 gene fusion in acute leukemia. Leukemia. 2008. 22:678–85.
Article
5.Carlson KM., Vignon C., Bohlander S., Martinez-Climent JA., Le Beau MM., Rowley JD. Identification and molecular characterization of CALM/AF10fusion products in T cell acute lymphoblastic leukemia and acute myeloid leukemia. Leukemia. 2000. 14:100–4.
Article
6.Kumon K., Kobayashi H., Maseki N., Sakashita A., Sakurai M., Tanizawa A, et al. Mixed-lineage leukemia with t(10;11)(p13;q21): an analysis of AF10-CALM and CALM-AF10 fusion mRNAs and clinical features. Genes Chromosomes Cancer. 1999. 25:33–9.
7.Asnafi V., Radford-Weiss I., Dastugue N., Bayle C., Leboeuf D., Charrin C, et al. CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRgammadelta lineage. Blood. 2003. 102:1000–6.
8.Dik WA., Brahim W., Braun C., Asnafi V., Dastugue N., Bernard OA, et al. CALM-AF10+ T-ALL expression profiles are characterized by overexpression of HOXA and BMI1 oncogenes. Leukemia. 2005. 19:1948–57.
Article
9.Okada Y., Jiang Q., Lemieux M., Jeannotte L., Su L., Zhang Y. Leukaemic transformation by CALM-AF10 involves upregulation of Hox-a5 by hDOT1L. Nat Cell Biol. 2006. 8:1017–24.
Article
10.Kim KH., Han JY. Simultaneous reverse transcription-polymerase chain reaction for detection of 7 gene rearrangements in acute leukemia. Korean J Clin Pathol. 2001. 21:24–33.
11.Sundstrom C., Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer. 1976. 17:565–77.
12.Sitwala KV., Dandekar MN., Hess JL. HOX proteins and leukemia. Int J Clin Exp Pathol. 2008. 1:461–74.
13.Okada Y., Feng Q., Lin Y., Jiang Q., Li Y., Coffield VM, et al. hDOT1L links histone methylation to leukemogenesis. Cell. 2005. 121:167–78.
Article
14.Van Vlierberghe P., van Grotel M., Tchinda J., Lee C., Beverloo HB., van der Spek PJ, et al. The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia. Blood. 2008. 111:4668–80.
Article
Full Text Links
  • KJLM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr